COPD exacerbation phenotypes: The next frontier
- PMID: 31468623
- DOI: 10.1111/resp.13693
COPD exacerbation phenotypes: The next frontier
Keywords: airway inflammation phenotype; blood eosinophil; chronic obstructive pulmonary disease.
Comment on
-
Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.Respirology. 2020 Mar;25(3):259-266. doi: 10.1111/resp.13660. Epub 2019 Aug 6. Respirology. 2020. PMID: 31385389
References
REFERENCES
-
- Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob. Health Epidemiol. Genom. 2018; 3: e4.
-
- Brusselle G, Pavord ID, Landis S, Pascoe S, Lettis S, Morjaria N, Barnes N, Hilton E. Blood eosinophil levels as a biomarker in COPD. Respir. Med. 2018; 138: 21-31.
-
- Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur. Respir. J. 2019; 53: pii: 1900164.
-
- Ghebre MA, Pang PH, Diver S, Desai D, Bafadhel M, Haldar K, Kebadze T, Cohen S, Newbold P, Rapley L et al. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles. J. Allergy Clin. Immunol. 2018; 141: 2027-36.e12.
-
- FWS K, Chan KP, Ngai J, Ng SS, Yip WH, Ip A, Chan TO, DSC H. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations. Respirology 2020; 25: 259-66.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
